Sutton’s Law, Substance Use Disorder, and Treatment of Hepatitis C in the Era of Direct-acting Antivirals
- 21 January 2020
- journal article
- editorial
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (4) , 988-989
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting AntiviralsJournal of General Internal Medicine, 2019
- Cost-Effective but Bad for Health? Hepatitis C Treatment, Moral Hazard, and Opportunity CostClinical Gastroenterology and Hepatology, 2017
- Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-SavingClinical Gastroenterology and Hepatology, 2017
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsCirculation, 2015
- Limited Access to New Hepatitis C Virus Treatment Under State Medicaid ProgramsAnnals of Internal Medicine, 2015